Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated May 25, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adial Pharmaceuticals, Inc.
| 240.8K |
—
|
—
| +23.59% | 1.26M |
May 23
| |||||||
Avalon Globocare Corp.
|
0
|
—
|
—
|
—
|
0
|
Jan 1 - Jan 1
| |||||||
Adial Pharmaceuticals, Inc.
| -166.67K |
—
|
—
| -14.03% | 1.02M |
Dec 30
| |||||||
Adial Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 22
| |||||||
Adial Pharmaceuticals, Inc.
| 250K |
—
|
—
| +26.66% | 1.19M |
Feb 23
| |||||||
Adial Pharmaceuticals, Inc.
| 20.6K |
$2.67 | $55,070.62 | +2.25% | 937.65K |
Nov 29 - Nov 30
| |||||||
Sysorex, Inc.
| 50K |
—
|
—
| +200.00% | 75K |
Sep 3
| |||||||
Sysorex, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Adial Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 8
| |||||||
Adial Pharmaceuticals, Inc.
| 201.11K |
—
|
—
| +28.09% | 917.05K |
Jan 26
| |||||||
Adial Pharmaceuticals, Inc.
| 25K |
$1.30 | $32,551.68 | +3.62% | 715.94K |
Mar 25 - Mar 26
| |||||||
Adial Pharmaceuticals, Inc.
| 54.17K |
—
|
—
| +8.51% | 690.94K |
Mar 3
| |||||||
Avalon Globocare Corp.
|
0
|
—
|
—
|
—
|
0
|
Feb 25
| |||||||
Adial Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 10
| |||||||
Adial Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 12
| |||||||
Adial Pharmaceuticals, Inc.
| 169.03K |
—
|
—
| +22.25% | 928.63K |
Jul 31
| |||||||
Adial Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Avalon Globocare Corp.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||